Buy Cyient; target of Rs 2700: Emkay Global Financial
Emkay Global Financial is bullish on Cyient has recommended buy rating on the stock with a target price of Rs 2700 in its research report dated January 26, 2024.31-01-2024
Buy Cyient; target of Rs 2700: Emkay Global Financial
Emkay Global Financial is bullish on Cyient has recommended buy rating on the stock with a target price of Rs 2700 in its research report dated January 26, 2024.Cyient DLM Ltd - 543933 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report issued by ICRA for the quarter ended 31 December 2023.Cyient DLM Ltd - 543933 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcripts for the investor conference call held on 23 January 2024.Cyient shares in focus after Q3 net profit tanks 17% sequentially
Cyient posted a 17.4 percent sequential decline in consolidated net profit to Rs 147.2 crore in the December quarterCyient Q3 FY24 Results Live: Profit Falls by 5.64% YOY
Cyient Q3 FY24 Results Live: Revenue increased by 12.56% YoY & profit decreased by 5.64% YoYCyient Limited Q3 results: Net profit drops 2% to 153 crore, firm narrows guidance for largest unit
The firm cites the drop in company's consolidated net profit is due to higher employee costs and narrowed the revenue growth outlook for its largest business unit.Cyient DLM Ltd - 543933 - Statement Of Deviation & Variation Pursuant To Regulation 32 Of SEBI Lodr Regulations 2015
Statement of Deviation and Variation pursuant to regulation 32 of SEBI LoDR Regulations 2015.Cyient DLM Ltd - 543933 - Appointment Of Chief Technical Officer - Additional Details Required Under SEBI Circular Dated July 13, 2023, For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Intimation of appointment of Chief Technical officer and additional details required under SEBI LODR, Regulation 2015Cyient DLM Ltd - 543933 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Q3 Financial Results of the Company.